PDCD1 and cancer: These new potential treatments for advanced head and neck cancer include new applications of anti-PD-1 monoclonal antibodies (described in Section 3), alternative checkpoint targets, combination strategies for immunotherapies and other treatments, oncolytic virus therapies, therapeutic cancer vaccines, and adoptive cell therapies.